Gyre Therapeutics, Inc. (GYRE)
7.12
-0.11
(-1.52%)
USD |
NASDAQ |
Apr 02, 16:00
7.14
+0.02
(+0.28%)
After-Hours: 20:00
Gyre Therapeutics Shareholders Equity (Quarterly) : 106.03M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Neogen Corp. | 2.104B |
| Zoetis, Inc. | 3.331B |
| Marker Therapeutics, Inc. | 16.80M |
| Savara, Inc. | 203.13M |
| Pulmatrix, Inc. | 3.81M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 166.13M |
| Total Liabilities (Quarterly) | 23.00M |
| Debt to Equity Ratio | 0.0089 |
| Current Ratio | 5.598 |
| Net Debt Paydown Yield | 0.03% |